Recent News

FDA warning

Inspection Triggers FDA Warning for Mesh Manufacturer

The U.S. Food and Drug Administration (FDA) issued a warning letter to Endo International PLC following an inspection of the pharmaceutical company’s facility in Minnetonka, Minn. According to the FDA, Endo violated three federal regulations governing how it manufactures some of its urological devices. Endo’s Minnesota facility is run by its subsidiary, American Medical Systems […]

Apr 23, 2014 Read More...

Vials of Testosterone Used for Injection

Manufacturers of Testosterone-Boosting Drugs Could Face Multidistrict Litigation

AndroGel, the controversial testosterone replacement gel linked to heart attacks in men, is spending almost as much time in court as it is in medicine cabinets these days. A motion was filed March 28 that seeks to consolidate more than three dozen pending federal lawsuits against the gel’s makers, Abbott Laboratories and AbbVie Inc., into […]

Apr 17, 2014 Read More...

Transvaginal Mesh Courthouse

Texas Jury Awards Woman $1.2M in J&J Transvaginal Mesh Case

A Texas jury recently ordered that Johnson & Johnson must pay $1.2 million to a former nurse who was injured by one of the manufacturer’s mesh slings used to treat incontinence. Plaintiff Linda Batiste filed a lawsuit against the pharmaceutical giant when the TVT-O mesh sling implanted in her body to treat stress urinary incontinence […]

Apr 9, 2014 Read More...

Actos Trial Results in 9 Billion Dollar Verdict

Actos Verdict: Takeda, Eli Lilly Must Pay $9 Billion for Hiding Bladder Cancer Risks

A Louisiana federal jury awarded a man $9 billion in punitive damages and $1.5 million in compensatory damages from Takeda Pharmaceuticals and marketing partner Eli Lilly & Co., claiming the drug companies hid the risks of bladder cancer linked to their Actos diabetes drug. Terrence Allen had been taking Actos to treat his Type 2 […]

Apr 8, 2014 Read More...

Delores Cipriano alleges Actos gave her bladder cancer

Billion-Dollar Lawsuit Against Actos Resumes Today

The multibillion-dollar trial against Takeda Pharmaceuticals, over Actos and the Type 2 diabetes drug’s link to bladder cancer, resumes today after a two-week hiatus, with experts ready to deliver potentially damaging testimony against the drugmaker. Bertha Triana, 80, and Delores Cipriano, 81, say they developed bladder cancer after taking Actos. Their attorneys are expected to […]

Apr 7, 2014 Read More...

Black Box Warning on Testosterone Pills

Advocacy Groups: Testosterone Products Need Black-Box Warning About Heart Attack Risk

Despite a growing number of studies pointing to increased heart attack risk with testosterone replacement therapy drugs, the U.S. Food and Drug Administration (FDA) has yet to require warning labels on testosterone products. Drug companies, including AbbVie Inc., which manufactures AndroGel, are marketing their testosterone replacement drugs aggressively to treat “Low T” – a low […]

Apr 1, 2014 Read More...

Loading